HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Clinical trials for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets tough leukemia in patients with RUNX1 mutation
Disease control TerminatedThis study tested a combination of two drugs, omacetaxine and venetoclax, in 24 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that had returned or not responded to treatment. All participants had a specific genetic change called RUNX1. The goal was to…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Experimental combo for tough lung side effect fails to launch
Disease control TerminatedThis study tested two drugs, infliximab and intravenous immunoglobulin (IVIG), to treat a serious lung inflammation called pneumonitis that did not get better with steroids. The inflammation was a side effect of cancer immunotherapy. Only one person enrolled before the study was …
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Cancer Patients' COVID-19 treatment trial halted early
Disease control TerminatedThis early-phase trial tested whether combining two immune-boosting drugs, rintatolimod and interferon alpha-2b, could help cancer patients clear COVID-19. Only 4 patients enrolled before the study was terminated. The goal was to find a safe dose and see if the treatment could re…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Cancer brain metastasis drug combo trial halted early
Disease control TerminatedThis study tested two drugs, bintrafusp alfa and pimasertib, in people whose cancer had spread to the brain. The goal was to find the best dose and see if the combination could slow or stop tumor growth. The trial was stopped early after enrolling only 8 participants, so no clear…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New approaches aim to ease recovery after stem cell transplants in vulnerable patients
Symptom relief TerminatedThis study tested two approaches—supportive and palliative care (focusing on symptom relief) and clinical management of other health problems (like heart or lung disease)—to improve quality of life and survival after a donor stem cell transplant. It included 458 older, weak, or f…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:24 UTC
-
Can tech boost depression treatment in cancer care?
Symptom relief TerminatedThis study looked at whether adding technology to standard depression care helps cancer patients feel better. It involved 297 adults receiving cancer treatment who had significant depression. Researchers compared a tech-enhanced approach to usual care, focusing on treatment engag…
Matched conditions: HEMATOPOIETIC AND LYMPHOID CELL NEOPLASM
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated May 26, 2026 03:54 UTC